Abstract
Alzheimer's (AD) is a neurological disorder that worsens the quality of life and raises the need for caretakers with no available curative medication for the illness. Therefore, there is a growing concern about the use of herbal medicine, as it is cost-effective, has minimal side effects, and could slow AD progression and enhance patients' quality of life, making it a viable adjuvant therapy. Pithecellobium dulce (Roxb.) Benth F. Leguminosae is widely consumed in several countries to treat various illnesses. This study used in vitro, in vivo, and in silico studies to investigate the potential use of P. dulce leaves' methanolic extract in treating and preventing Alzheimer's disease.
Cite
CITATION STYLE
Elhewehy, A. A., El-fishawy, A. M., El-Rashedy, A. A., Fayez, A. M., Fayed, M. A. A., & Mohsen, E. (2025). UPLC-ESI–MS/MS phytochemical profile, in vitro, in vivo, and in silico anti-Alzheimer’s activity assessment of Pithecellobium dulce (Roxb.) Benth. leaves. Future Journal of Pharmaceutical Sciences, 11(1). https://doi.org/10.1186/s43094-025-00776-9
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.